Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

New book tackles racism in medicine

New Anti-Racist Medicine textbook explores racism’s impact on healthcare, research and education, and offers guidance for delivering more equitable care.

Onima Chowdhury receives Cancer Research UK clinical trial grant

Congratulations to Dr Onima Chowdhury, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.

Oxford scientists uncover how the brain resolves emotional ambiguity

Non-invasive ultrasound study reveals causal role of the amygdala in interpreting uncertain emotions.

£3 million Department of Health and Social Care grant to fund landmark prostate cancer surgery trial

Professor Prasanna Sooriakumaran, from the University of Oxford’s Nuffield Department of Surgical Sciences (NDS), has been awarded a £3 million grant from the Department of Health and Social Care to lead a major new clinical trial that could transform the global treatment of early, lethal prostate cancer.

Declining water levels linked to air pollution and depression severity

New study highlights how water management and environmental change may be shaping mental health around the Great Salt Lake in Utah, USA.

Student Wellbeing at Oxford: Waves of Evidence

The authors of a new paper explain how a new methodology helped them better understand student wellbeing at Oxford and what more could be done to support mental health.

New study finds that stored sperm deteriorates across the animal kingdom

Current World Health Organization (WHO) guidelines typically recommend 2–7 days of abstinence before taking semen samples or assisted reproduction. However, a new study published today and led by Oxford University researchers suggests that regular ejaculation – whether through sexual activity or masturbation – results in higher quality sperm, with less DNA damage.

NDPCHS hosts first Annual Showcase and Lecture at the Oxford Union

Nuffield Department of Primary Care Health Sciences (NDPCHS) hosted its first Annual Showcase and Lecture at the Oxford Union, bringing together leading voices in primary care research, education and global health innovation, including a keynote address by Lord Vallance.

Collaboration with the Nepal Public Health Foundation (NPHF) explores maternal health and epilepsy

A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.

Blood test may improve survival of childhood cancer in Africa

A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.

World Happiness Report 2026 shows a complex global picture of social media and happiness

Heavy social media use appears to be contributing to the drop in wellbeing among young people in English-speaking countries and Western Europe, especially among girls, according to findings published today (19 March) in the 2026 edition of the World Happiness Report.

GSK, University of Oxford and Imperial College London launch centre to create computer models of lungs, liver, kidneys and cartilage

A new research centre backed with £11 million from GSK will build open-source digital twins of organs for in-silico research to advance disease understanding and speed up development of new drugs.

University of Oxford receives further £2m gift from Fondation Docteur Sadok Besrour to strengthen academic primary care in Tunisia

New investment at Oxford’s Nuffield Department of Primary Care Health Sciences will support academic leadership, research capacity and training in Tunisia

International trial finds rapid diagnostic testing alone does not reduce antibiotic prescribing for respiratory infections

Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative study led by the University of Oxford and University of Antwerp, report that point-of-care diagnostic testing, when used alone is unlikely to reduce antibiotic prescribing for respiratory tract infections in primary care. The findings indicate that testing must be embedded within broader antimicrobial stewardship strategies to be effective.

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.

New research reveals how development and sex shape the brain

Two companion studies, published in Cell Genomics, reveal how brain development lays the foundation for both shared and sex-specific circuits, redefining how neural diversity arises. A Preview article linked to the report highlights the broader significance of these findings and places them in context for the field.

New research reveals why some oesophageal cancers are so hard to treat

Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.

New study reveals how blood cell production responds to parasite infection

Research led by the Nerlov Group in the Medical Research Council (MRC) Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.

Anchoring a key immune molecule boosts T cell responses

Researchers at the Kennedy Institute of Rheumatology have found that physically resisting the formation of an immunological synapse actually promotes a stronger immune response. The findings could help explain how immune responses become weakened in cancer and chronic infection and inform the design of more effective vaccines.

Load More